nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

03.03.2022 | Correspondence

Risk of Transfusion-Transmitted Hepatitis E Virus: Correspondence

verfasst von: Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, we would like to comment on the publication “The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations [1].” Wong et al. concluded that “The higher rates of HEV infection in blood from older donors and donors who are non-professional workers may provide insights into targeted groups for blood screening [1].” We agree that the estimation of risk for the transmission of HEV via blood transfusion is interesting. The present study reported on the results from serological screening. The diagnostic property of the serological test is a major concern. Because the diagnostic serological test may have limitations, the true HEV contamination rate in donated blood samples may differ from the rate reported by Wong et al. …

Wong LP, Lee HY, Khor CS et al (2022) The risk of transfusion-transmitted hepatitis E virus: evidence from seroprevalence screening of blood donations. Indian J Hematol Blood Transfus 38:145–152. https://doi.org/10.1007/s12288-021-01428-7CrossRefPubMed

Al Absi ES, Al-Sadeq DW, Khalili M, Younes N, Al-Dewik N, Abdelghany SK, Abouzid SS, Al Thani AA, Yassine HM, Coyle PV, Nasrallah GK (2021) The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E. BMC Gastroenterol 21(1):266CrossRef

Zhang Q, Zong X, Li D, Lin J, Li L (2020) Performance evaluation of different commercial serological kits for diagnosis of acute hepatitis E viral infection. Pol J Microbiol 69(2):217–222CrossRef

Titel: Risk of Transfusion-Transmitted Hepatitis E Virus: Correspondence
verfasst von: Rujittika Mungmunpuntipantip
Viroj Wiwanitkit
Publikationsdatum: 03.03.2022
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2022
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-022-01530-4

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Risk of Transfusion-Transmitted Hepatitis E Virus: Correspondence

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Splenectomy in İmmune Thrombocytopenia: A Retrospective Analysis of 25-Year Follow-up Data from a Tertiary Health Clinic

SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India

Reinduction of the Temporarily Deferred Donors for Laying the Foundation of Safe and Sustainable Blood Supplies: A Review in the Indian Context

Significance of Adopting Nucleic Acid Amplification Technique for Blood Donor Screening in a Resource Limited Setting: A Study from a Single Centre in South India

Cardiac MRI for Iron Overload in pediatric thalassemia patients– Right Age to Start in a Resource Constrained Environment

Gastric MALT Lymphoma: A 8-Year Experience

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie